Sellar Region

  • César R. Lacruz
  • Javier Saénz de Santamaría
  • Ricardo H. Bardales
Part of the Essentials in Cytopathology book series (EICP, volume 13)


Pituitary specimens are frequently submitted for an intraoperative diagnosis being one of the most commonly handled neurosurgical specimens. Common indications for intraoperative assessment of sellar region lesions include the following: (1) ensure an appropriate tissue allocation and processing for accurate diagnosis, (2) confirm the presence of pituitary adenoma, (3) distinguish pituitary adenoma from other regional lesions, and (4) identify an unexpected lesion. Due to the peculiar location of the pituitary gland, just above the sphenoid sinus, a transnasal surgical approach is the rout by which biopsy or excision of most sellar lesions is performed. Because specimens obtained by this technique are slippery tiny fragments, cytologic preparations play a crucial diagnostic role on pituitary intraoperative consultation. In this chapter, the cytomorphologic features and differential diagnosis of neoplastic and nonneoplastic processes involving the pituitary gland/sellar region are revised.


Intraoperative brain assessment Cytology Squash preparation Smear preparation Sellar lesions Sellar tumors Pituitary adenoma Invasive pituitary adenoma Pituitary carcinoma Craniopharingyoma Adamantinomatous craniopharyngioma Papillary craniopharyngioma Rathke cleft cyst Pituicytoma Granular cell tumor Spindle cell oncocytoma Pituitary blastoma Lymphocytic hypophysitis Hypothalamic hamartoma 

Suggested Reading

  1. Aylwin SJ, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary. 2016;19:544–6.CrossRefGoogle Scholar
  2. Boari N, Losa M, Mortini P, Snider S, Terreni MR, Giovanelli M. Intrasellar paraganglioma: a case report and review of the literature. Acta Neurochir. 2006;148:1311–4.CrossRefGoogle Scholar
  3. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46:161–5.CrossRefGoogle Scholar
  4. Brat DJ, Scheithauer BW, Staugaitis SM, Holtzman RN, Morgello S, Burger PC. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol. 2000;24:362–8.CrossRefGoogle Scholar
  5. Buslei R, Nolde M, Hofmann B, Meissner S, et al. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109:589–97.CrossRefGoogle Scholar
  6. Ceyhan K, Yagmurlu B, Dogan BE, Erdogan N, Bulut S, Erekul S. Cytopathologic features of pituitary carcinoma with cervical vertebral bone metastasis: a case report. Acta Cytol. 2006;50:225–30.CrossRefGoogle Scholar
  7. Chen KT. Crush cytology of pituicytoma. Diagn Cytopathol. 2005;33:255–7.CrossRefGoogle Scholar
  8. Cohen-Gadol AA, Pichelmann MA, Link MJ, Scheithauer BW, et al. Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature review. Mayo Clin Proc. 2003;78:567–75.CrossRefGoogle Scholar
  9. Coons SW, Rekate HL, Prenger EC, Wang N, et al. The histopathology of hypothalamic hamartomas: study of 57 cases. J Neuropathol Exp Neurol. 2007;66:131–41.CrossRefGoogle Scholar
  10. Daneshbod Y, Monabati A, Kumar PV, Taghipoor M, Bedayat GR. Intraoperative cytologic crush preparation findings in craniopharyngioma. A study of 12 cases. Acta Cytol. 2005;49:7–10.CrossRefGoogle Scholar
  11. Devi S, Ganger A, Sharma S, Saxena R. Sphenoid mucocele with unusual panhypopituitarism. BMJ Case Rep. 2016;2016:pii: bcr2015214218. Scholar
  12. Gomez-Hernandez K, Ezzat S, Asa SL, Mete Ö. Clinical implications of accurate subtyping of pituitary adenomas: perspectives from the treating physician. Turk Patoloji Derg. 2015;31(Suppl 1):4–17.PubMedGoogle Scholar
  13. Hagel C, Buslei R, Buchfelder M, Fahlbusch R, et al. Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells. Pituitary. 2017;20:211–7.CrossRefGoogle Scholar
  14. Hansen I, Petrossians P, Thiry A, Flandroy P, et al. Extensive inflammatory pseudotumor of the pituitary. J Clin Endocrinol Metab. 2001;86:4603–10.CrossRefGoogle Scholar
  15. He W, Chen F, Dalm B, Kirby PA, Greenlee JD. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary. 2015;18:159–68.CrossRefGoogle Scholar
  16. Heaney AP. Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011;96:3649–60.CrossRefGoogle Scholar
  17. Hölsken A, Sill M, Merkle J, Schweizer L, et al. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun. 2016;4:20.CrossRefGoogle Scholar
  18. Inagawa H, Ishizawa K, Mitsuhashi T, et al. Giant invasive pituitary adenoma extending into the sphenoid sinus and nasopharynx. Report of a case with intraoperative cytologic diagnosis. Acta Cytol. 2005;49:452–6.CrossRefGoogle Scholar
  19. Kim JS, Lee YS, Jung MJ, Hong YK. The predictive value of pathologic features in pituitary adenoma and correlation with pituitary adenoma recurrence. J Pathol Transl Med. 2016;50:419–25.CrossRefGoogle Scholar
  20. Kleinschmidt-DeMasters BK, Lopes MB. Update on hypophysitis and TTF-1 expressing sellar region masses. Brain Pathol. 2013;23:495–514.CrossRefGoogle Scholar
  21. Kleinschmidt-DeMasters BK, Lopes MB, Prayson RA. An algorithmic approach to sellar region masses. Arch Pathol Lab Med. 2015;139:356–72.CrossRefGoogle Scholar
  22. Kontogeorgos G, Bassiouka I, Giannou P, Vamvassakis E, Rologis D, Orphanidis G. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry. Acta Cytol. 1995;39:141–52.PubMedGoogle Scholar
  23. Kontogeorgos G, Mourouti G, Kyrodimou E, Liapi-Avgeri G, Parasi E. Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells. Acta Neuropathol. 2006;112:21–8.CrossRefGoogle Scholar
  24. Lee TJ, Li SP, Fu CH, Huang CC, et al. Extensive paranasal sinus mucoceles: a 15-year review of 82 cases. Am J Otolaryngol Head Neck Med Surg. 2009;30:234–8.Google Scholar
  25. Liu JK, Patel J, Eloy JA. The role of temozolomide in the treatment of aggressive pituitary tumors. J Clin Neurosci. 2015;22:923–9.CrossRefGoogle Scholar
  26. Madhavan M, George J, Jafri JA, Idris Z. Intraventricular squamous papillary craniopharyngioma. Report of a case with intraoperative imprint cytology. Acta Cytol. 2005;49:431–4.CrossRefGoogle Scholar
  27. McDonald WC, Banerji N, McDonald KN, Ho B, Macias V, Kajdacsy-Balla A. Steroidogenic factor 1, Pit-1, and adrenocorticotropic hormone: a rational starting place for the immunohistochemical characterization of pituitary adenoma. Arch Pathol Lab Med. 2017;141:104–12.CrossRefGoogle Scholar
  28. Mete O, Lopes MB, Asa SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol. 2013;37:1694–9.CrossRefGoogle Scholar
  29. Murakami K, Muraishi K, Ikeda H, Yoshimoto T. Plasma cell granuloma of the pituitary gland. Surg Neurol. 2001;56:247–51.CrossRefGoogle Scholar
  30. Ng H-K. Smears in the diagnosis of pituitary adenomas. Acta Cytol. 1998;42:614–8.CrossRefGoogle Scholar
  31. Nguyen G-K, Johnson ES, Mielke BW. Comparative cytomorphology of pituitary adenomas and oligodendrogliomas in intraoperative crush preparations. Acta Cytol. 1992;36:661–7.PubMedGoogle Scholar
  32. Parwani AV, Taylor DC, Burger PC, Erozan YS, Olivi A, Ali SZ. Keratinized squamous cells in fine needle aspiration of the brain. Cytopathologic correlates and differential diagnosis. Acta Cytol. 2003;47:325–31.CrossRefGoogle Scholar
  33. Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol. 1999;97:377–82.CrossRefGoogle Scholar
  34. Pegolo G, Buckwalter JG, Weiss MH, Hinton DR. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior. Acta Cytol. 1995;39:887–92.PubMedGoogle Scholar
  35. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. 1997;79:804–12.CrossRefGoogle Scholar
  36. Piccirilli M, Maiola V, Salvati M, D'Elia A, et al. Granular cell tumor of the neurohypophysis: a single-institution experience. Tumori. 2014;100:160e–4e.CrossRefGoogle Scholar
  37. Policarpio-Nicolas ML, Le BH, Mandell JW, Lopes MB. Granular cell tumor of the neurohypophysis: report of a case with intraoperative cytologic diagnosis. Diagn Cytopathol. 2008;36:58–63.CrossRefGoogle Scholar
  38. Roque A, Odia Y. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol. 2017;6:95–9.CrossRefGoogle Scholar
  39. Salame K, Ouaknine GE, Yossipov J, Rochkind S. Paraganglioma of the pituitary fossa: diagnosis and management. J Neuro-Oncol. 2001;54:49–52.CrossRefGoogle Scholar
  40. Sav A, Rotondo F, Syro LV, Di Ieva A, Cusimano MD, Kovacs K. Invasive, atypical and aggressive pituitary adenomas and carcinomas. Endocrinol Metab Clin N Am. 2015;44:99–104.CrossRefGoogle Scholar
  41. Scheithauer BW, Horvath E, Abel TW, Robital Y, et al. Pituitary blastoma: a unique embryonal tumor. Pituitary. 2012;15:365–73.CrossRefGoogle Scholar
  42. Schneiderhan TM, Beseoglu K, Bergmann M, Neubauer U, et al. Sellar atypical teratoid/rhabdoid tumours in adults. Neuropathol Appl Neurobiol. 2001;37:326–9.CrossRefGoogle Scholar
  43. Sekine S, Shibata T, Kokubu A, et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161:1997–2001.CrossRefGoogle Scholar
  44. Sibal L, Ball SG, Connolly V, James RA, et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004;7:157–63.ç.CrossRefGoogle Scholar
  45. Simms NM, Brown WE, French LA. Mucocele of the sphenoid sinus presenting as an intrasellar mass. Case report. J Neurosug. 1970;32:708–10.CrossRefGoogle Scholar
  46. Smith AR, Elsheikh TM, Silverman JF. Intraoperative cytologic diagnosis of suprasellar and sellar cystic lesions. Diagn Cytopathol. 1999;20:137–47.CrossRefGoogle Scholar
  47. Sy J, Ang LC. Cytomorphologic spectrum of mixed pituitary adenoma-gangliocytomas. A report of two cases. Acta Cytol. 2010;54:981–4.PubMedGoogle Scholar
  48. Tena-Suck M, Salinas-Lara C, Vega-Orozco R, Rembao-Bojorquez D, Gelista N. Crush intraoperatory analysis in craniopharyngioma. Diagn Cytopathol. 2012;40:865–70.CrossRefGoogle Scholar
  49. Wang H, Liang J, Yong WH, Sullivan P. Metastatic pituitary carcinoma to cervical lymph node: diagnosis by fine needle aspiration and review of the literature. Acta Cytol. 2017;61:242–6.CrossRefGoogle Scholar
  50. Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28:E4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • César R. Lacruz
    • 1
  • Javier Saénz de Santamaría
    • 2
  • Ricardo H. Bardales
    • 3
  1. 1.Professor of PathologyComplutense University School of MedicineMadridSpain
  2. 2.Professor of PathologyUniversity Hospital Extremadura, Medical SchoolBadajozSpain
  3. 3.Pathologist, Director Ultrasound-guided Fine Needle Aspiration ServiceOutpatient Pathology Associates / Precision PathologySacramentoUSA

Personalised recommendations